Interim / Quarterly Report • Sep 16, 2025
Interim / Quarterly Report
Open in ViewerOpens in native device viewer
Interim Condensed Consolidated Financial Statements
For the period from 1 January 2025 to 30 June 2025
| 30 June 2025 Unaudited €000 |
30 June 2024 Unaudited €000 |
|
|---|---|---|
| Revenue Administrative expenses |
193 (499) |
228 (499) |
| Operating loss | ___ (306) |
___ (271) |
| Share of profit from investments accounted for using equity method |
4.943 | 2.944 |
| Profit before tax | ___ 4.637 |
___ 2.673 |
| Tax | - | - |
| Profit for the period | ___ 4.637 ========= |
___ 2.673 ========= |
| Other comprehensive income Share of reserves of investments accounted for using equity method |
9 | 27 |
| Total comprehensive income for the period | ___ 4.646 ========= |
___ 2.700 ========= |
| Profit per share attributable to the shareholders of the Company (cent per shares): Basic and fully distributed |
3,38 | 1,95 |
| ========= | ========= |
| 30 June 2025 Unaudited €000 |
31 December 2024 Audited €000 |
|
|---|---|---|
| Assets | ||
| Non-current assets | ||
| Property, plant and equipment | 41 | 46 |
| Investment property | 323.933 | 323.421 |
| Investments accounted for using the equity method | 68.869 _____ |
63.916 _____ |
| 392.843 _____ |
387.383 _____ |
|
| Current assets | ||
| Financial assets at amortised cost | 9.487 | 9.548 |
| Other non-financial assets Cash and cash equivalents |
611 7.190 |
571 9.201 |
| _____ 17.288 |
_____ 19.320 |
|
| Total assets | _____ 410.131 |
_____ 406.703 |
| =========== | =========== | |
| Equity and liabilities | ||
| Capital and reserves | ||
| Share capital | 50.650 | 50.650 |
| Own shares | (14) | - |
| Fair value reserve Revenue reserve |
107.458 17.236 |
107.449 17.236 |
| Other reserves | (15) | (15) |
| Retained earnings | 177.333 | 175.583 |
| Total equity | _____ 352.648 |
_____ 350.903 |
| Non-current liabilities | _____ | _____ |
| Deferred tax liabilities | 55.426 _____ |
55.426 _____ |
| 55.426 _____ |
55.426 _____ |
|
| Current liabilities | ||
| Trade and other payables | 247 | 374 |
| Dividends payable | 1.810 _____ |
- _____ |
| 2.057 _____ |
374 _____ |
|
| Total liabilities | 57.483 | 55.800 |
| Total equity and liabilities | _____ 410.131 |
_____ 406.703 |
| =========== | =========== |
| Attributable to owners of the Company | |||||||
|---|---|---|---|---|---|---|---|
| Share | Own | Fair value | Other | Revenue | Retained | Total | |
| Capital | shares | reserve | reserves | Reserve | Earnings | equity | |
| €000 | €000 | €000 | €000 | €000 | €000 | €000 | |
| Six months until 30 June 2025 Balance at 1 January 2025 |
50.650 | - | 107.450 | 17.236 | (15) | 175.583 | 350.903 |
| Comprehensive income | __ | __ | __ | __ | ____ | ___ | ____ |
| Profit for the period | - | - | - | - | - | 4.637 | 4.637 |
| Other comprehensive income | __ | ___ | __ | __ | ____ | ___ | ____ |
| Share of fair value reserves and other reserves of associated companies | - | - | 9 | - | - | - | 9 |
| Total other comprehensive income | __ | ___ | __ | __ | ____ | ___ | ____ |
| - | - | 9 | - | - | - | 9 | |
| Total comprehensive income for the period | __ | ___ | __ | __ | ____ | ___ | ____ |
| - | - | 9 | - | - | 4.637 | 4.646 | |
| Transactions with Company's owners Dividends declared from the profits of 2023 Purchase of own shares |
__ - - |
___ - (14) |
__ - - |
__ - - |
____ - - |
___ (2.888) - |
____ (2.888) (14) |
| Total transactions | __ | ___ | __ | __ | ____ | ___ | ____ |
| with Company's owners | - | (14) | - | - | - | (2.888) | (2.902) |
| Balance at 30 June 2024 | __ | ___ | __ | __ | ____ | ___ | ____ |
| (unaudited) | 50.650 | (14) | 107.459 | 17.236 | (15) | 177.333 | 352.648 |
| Six months until 30 June 2024 | ========= | ========== | ========= | ========= | =========== | ========== | ============ |
| Balance at 1 January 2024 | 50.916 | (266) | 107.421 | 17.236 | (15) | 174.236 | 349.528 |
| Comprehensive income | __ | ___ | __ | __ | ____ | ___ | ____ |
| Profit for the period | - | - | - | - | - | 2.673 | 2.673 |
| Other comprehensive income | __ | ___ | __ | __ | ____ | ___ | ____ |
| Share of fair value reserves and other reserves of associated companies | - | - | 27 | - | - | - | 27 |
| Total other comprehensive income | __ | ___ | __ | __ | ____ | ___ | ____ |
| - | - | 27 | - | - | - | 27 | |
| Total comprehensive income for the period | __ | ___ | __ | __ | ____ | ___ | ____ |
| - | - | 27 | - | - | 2.673 | 2.700 | |
| Transactions with Company's owners | __ | ___ | __ | __ | ____ | ___ | ____ |
| Dividends declared from the profits of 2022 | - | - | - | - | - | (2.743) | (2.743) |
| Cancellation of own shares | (266) | 266 | - | - | - | - | - |
| Total transactions | __ | ___ | __ | __ | ____ | ___ | ____ |
| with Company's owners | (266) | 266 | - | - | - | (2.743) | (2.743) |
| Balance at 30 June 2024 | __ | ___ | __ | __ | ____ | ___ | ____ |
| (unaudited) | 50.650 | - | 107.448 | 17.236 | (15) | 174.166 | 349.485 |
| ========= | ========= | ========== | ========= | =========== | ========== | =========== |
| 30 June 2025 Unaudited €000 |
30 June 2024 Unaudited €000 |
|
|---|---|---|
| Cash flows from operating activities Cash used in operations |
(636) | (540) |
| Net cash used in operating activities | ____ (636) |
____ (540) |
| ____ | ____ | |
| Cash flows from investing activities Dividends received |
- | 13 |
| Loans granted to related companies Proceeds from the disposal of financial assets at fair value |
(880) | (1.460) |
| through profit or loss | - | 534 |
| Additions of investment property Interest received |
(512) 31 |
(1.020) 29 |
| Net cash used in investing activities | _ (1.361) _ |
_ (1.904) _ |
| Cash flows from financing activities Purchase of own shares |
(14) | - |
| ____ | ____ | |
| Net cash from financing activities | (14) ____ |
- ____ |
| Net decrease in cash and cash equivalents | (2.011) | (2.444) |
| Cash and cash equivalents at the beginning of period | 9.201 | 10.158 |
| Cash and cash equivalents at the end of period | ____ 7.190 |
____ 7.714 |
| ========== | ========== |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.